Ignite Creation Date:
2024-05-05 @ 9:58 PM
Last Modification Date:
2024-10-26 @ 10:12 AM
Study NCT ID:
NCT01006980
Status:
COMPLETED
Last Update Posted:
2016-09-28
First Post:
2009-10-30
Brief Title:
A Study of Vemurafenib RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma BRIM 3
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Malignant Melanoma |
Keywords: